Annexon Biosciences

Annexon Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapies for patients with classical complement-mediated diseases. These diseases affect the body, brain, and eye and include serious autoimmune, neurodegenerative, and ophthalmic disorders. Annexon’s scientific approach targets C1q, the initiating molecule of the classical complement pathway, to block the inflammatory cascade before it starts. This distinct approach aims to provide meaningful benefits across a broad range of diseases by preventing the downstream inflammatory and tissue damage processes.

Annexon is rigorously advancing a diversified pipeline of product candidates across multiple clinical trials, with proof-of-concept data in Guillain-Barré syndrome, Huntington’s disease, and geographic atrophy. They are committed to bringing game-changing therapies to patients and are actively seeking talented individuals to join their experienced, collaborative, and driven team. Annexon is headquartered in Brisbane, California, and offers a competitive compensation package and a stimulating and rewarding workplace with flexible work schedules, remote opportunities, and the ability to achieve a work-life balance.

Annexon Biosciences offers a stimulating and rewarding work environment with flexible work schedules, remote opportunities, and the ability to achieve work-life balance. This enables employees to tailor their work arrangements to fit their individual needs and preferences, fostering a more fulfilling and productive work experience.

Annexon Biosciences offers a competitive benefits package that includes a competitive base salary and equity participation, an employee stock purchase plan, and a comprehensive health benefit package that includes medical, dental, vision, 401(k), and flexible spending plans. Additionally, they provide a stimulating and rewarding workplace that includes flexible work schedules, remote opportunities, and the ability to achieve a work-life balance. They are located in Brisbane, CA, with shuttle service from BART, CalTrain, and the Ferry.

Annexon Biosciences is a biopharmaceutical company committed to developing life-changing therapies for patients suffering from serious complement-mediated autoimmune, neurodegenerative and ophthalmic disorders. They are passionate about utilizing a distinct scientific approach to stop C1q and all inflammatory aspects of classical complement pathway activation before it starts. Their mission is to deliver transformative treatments that address the root causes of these diseases and improve the lives of those affected.

Annexon Biosciences promotes a culture that emphasizes a "Warrior Spirit" with a sense of urgency and a desire to be the best, but also encourages a "Sound Judgement" approach, focusing on what matters and applying wisdom in decision making. They value passion, innovation, and continuous learning, while prioritizing teamwork and following the golden rule. The company encourages its employees to have fun, celebrate successes, and enjoy the journey, fostering an environment where individuals can thrive and contribute to the mission of delivering transformative therapies to patients.

Annexon Biosciences prioritizes diversity, equity, inclusion, and belonging (DEIB) as crucial for their business success and the vitality of their communities. They have a steering committee dedicated to fostering a welcoming work environment where all employees feel appreciated and can be themselves. Internally, they focus on education, open dialogue, and accountability to improve DEIB efforts. Externally, they actively build a pipeline of underrepresented candidates, recruit and develop a diverse workforce, and ensure that Black, LatinX, and other underrepresented candidates have sustainable opportunities at Annexon. They hold their vendors to the same DEIB standards.